Erythrocin and Proair hfa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Erythrocin (erythromycin lactobionate) and Proair hfa (albuterol sulfate). Common drug interactions include gastrooesophageal reflux disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Erythrocin and Proair hfa. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Erythrocin?

Erythrocin has active ingredients of erythromycin lactobionate. It is often used in tooth abscess. eHealthMe is studying from 1,200 Erythrocin users. Check the latest studies of Erythrocin.

What is Proair hfa?

Proair hfa has active ingredients of albuterol sulfate. It is often used in asthma. eHealthMe is studying from 53,227 Proair hfa users. Check the latest studies of Proair hfa.



On Jul, 17, 2026

18 people who take Erythrocin and Proair hfa together, and have interactions are studied.

Erythrocin and Proair hfa drug interactions.

What are the common drug interactions of Erythrocin and Proair Hfa, by gender? *:

female:

  1. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  2. Nephrolithiasis (calculi in the kidneys)
  3. Nephropathy (damage to or disease of a kidney)
  4. Pain
  5. Fungal infection
  6. Headache (pain in head)
  7. Hysterectomy
  8. Impaired gastric emptying
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Death
  4. Renal tubular necrosis (death of kidney tubules)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the common drug interactions of Erythrocin and Proair Hfa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Death
  3. Renal failure (kidney dysfunction)
  4. Renal tubular necrosis (death of kidney tubules)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

50-59:

  1. Chronic kidney disease
  2. Dyspepsia (indigestion)
  3. Renal failure (kidney dysfunction)
  4. Renal injury (kidney injury)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  7. Impaired gastric emptying

60+:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Nephropathy (damage to or disease of a kidney)

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 66.67%
  2. High Blood Pressure: 9 people, 50.00%
  3. Infection: 8 people, 44.44%
  4. Pain: 8 people, 44.44%
  5. Depression: 8 people, 44.44%
  6. Cough: 7 people, 38.89%
  7. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 38.89%
  8. Nausea (feeling of having an urge to vomit): 6 people, 33.33%
  9. Neuralgia (pain in one or more nerves): 6 people, 33.33%
  10. Multiple Allergies (allergy to multiple agents): 5 people, 27.78%

* Approximation only. Some reports may have incomplete information.

Do you take Erythrocin and Proair hfa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Erythrocin and Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Erythrocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Proair hfa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Erythrocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Proair hfa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on erythromycin lactobionate and albuterol sulfate (the active ingredients of Erythrocin and Proair hfa, respectively), and Erythrocin and Proair hfa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: